Protagonist Therapeutics (PTGX) Treasury Shares (2022 - 2025)

Protagonist Therapeutics has disclosed Treasury Shares across 4 years of filings, most recently posting $1.3 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at $1.3 million, up 1607.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 1607.09% YoY), and the FY2025 annual result was $1.3 million, up 1607.09% from the prior year.
• Treasury Shares came in at $1.3 million for Q4 2025 at Protagonist Therapeutics, up from $75500.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2025 to a low of $75500.0 in Q4 2023.
• The 4-year median for Treasury Shares is $209250.0 (2022), against an average of $405634.6.
• Across the five-year window, Treasury Shares tumbled 67.12% in 2023 and soared 1607.09% in 2025, its largest moves.
• Protagonist Therapeutics' Treasury Shares stood at $694414.0 in 2022, then sank by 89.13% to $75500.0 in 2023, then changed by 0.0% to $75500.0 in 2024, then jumped by 1607.09% to $1.3 million in 2025.
• The last three Treasury Shares figures came in at $1.3 million (Q4 2025), $75500.0 (Q4 2024), and $75500.0 (Q4 2023), per Business Quant data.